Remogliflozin is an active pharmaceutical ingredient belonging to the gliflozin class of compounds. It is primarily used in pharmaceutical research and manufacturing as a raw material for developing medications targeting metabolic conditions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 329045-45-6
Remogliflozin etabonate
pharmaceutical raw material
Quetiapine Sulfoxide
pharmaceutical raw material
Tobramycin
pharmaceutical raw material
Peramivir
pharmaceutical raw material
Paclitaxel
pharmaceutical raw material
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl)methyl]pyrazol-3-yl]oxyoxane-3,4,5-triol
GSINGUMRKGRYJP-VZWAGXQNSA-N
CC1=C(C(=NN1C(C)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(C=C3)OC(C)C